Northern Trust Corp Amgen Inc Transaction History

Northern Trust Corp

$572 Billion
Q1 2024

A detailed history of Northern Trust Corp transactions in Amgen Inc stock. As of the latest transaction made, Northern Trust Corp holds 6,016,634 shares of AMGN stock, worth $1.92 Billion. This represents 0.3% of its overall portfolio holdings.

Number of Shares

6,016,634

Previous 6,413,022 6.18%

Holding current value

$1.92 Billion

Previous $1.85 Billion 7.39%

% of portfolio

0.3%

Previous 0.34%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $107 Million - $129 Million	-396,388 Reduced 6.18%	6,016,634 $1.71 Billion
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $144 Million - $163 Million	-564,603 Reduced 8.09%	6,413,022 $1.85 Billion
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $55.9 Million - $69.3 Million	255,463 Added 3.8%	6,977,625 $1.88 Billion
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $48.9 Million - $57.8 Million	-228,015 Reduced 3.28%	6,722,162 $1.49 Billion
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $35.6 Million - $43.4 Million	-157,599 Reduced 2.22%	6,950,177 $1.68 Billion

Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $12.3 Million - $15.7 Million	-53,851 Reduced 0.75%	7,107,776 $1.87 Billion
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $28.2 Million - $31.8 Million	-125,680 Reduced 1.72%	7,161,627 $1.61 Billion
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $79.5 Million - $88.4 Million	-344,416 Reduced 4.51%	7,287,307 $1.77 Billion
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $9.74 Million - $10.8 Million	-44,410 Reduced 0.58%	7,631,723 $1.85 Billion
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $31.1 Million - $35.6 Million	-156,508 Reduced 2.0%	7,676,133 $1.73 Billion
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $53.8 Million - $63.1 Million	253,637 Added 3.35%	7,832,641 $1.67 Billion
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $39.4 Million - $43.7 Million	-168,789 Reduced 2.18%	7,579,004 $1.85 Billion
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $38.3 Million - $44.7 Million	-172,772 Reduced 2.18%	7,747,793 $1.93 Billion
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $47.1 Million - $56.1 Million	-217,616 Reduced 2.67%	7,920,565 $1.82 Billion
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $37.5 Million - $41.7 Million	159,771 Added 2.0%	8,138,181 $2.07 Billion
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $945,927 - $1.16 Million	-4,782 Reduced 0.06%	7,978,410 $1.88 Billion
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $7.87 Million - $10.4 Million	-43,183 Reduced 0.54%	7,983,192 $1.62 Billion
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $123 Million - $158 Million	-650,425 Reduced 7.5%	8,026,375 $1.93 Billion
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $26 Million - $31.2 Million	-149,575 Reduced 1.69%	8,676,800 $1.68 Billion
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $16.8 Million - $19.7 Million	-100,897 Reduced 1.13%	8,826,375 $1.63 Billion
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $46.1 Million - $51.9 Million	-254,778 Reduced 2.77%	8,927,272 $1.7 Billion
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $72.9 Million - $85.1 Million	408,675 Added 4.66%	9,182,050 $1.79 Billion
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $55 Million - $62 Million	-296,777 Reduced 3.27%	8,773,375 $1.82 Billion
Q2 2018 Sep 18, 2018	SELL	$166.05 - $186.51 $11.3 Million - $12.7 Million	-68,200 Reduced 0.75%	9,070,152 $1.67 Billion
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $17.6 Million - $19.7 Million	-105,854 Reduced 1.15%	9,138,352 $1.69 Billion
Q1 2018 May 09, 2018	SELL	$169.43 - $198.0 $91.7 Million - $107 Million	-541,066 Reduced 5.53%	9,244,206 $1.58 Billion
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $7.54 Million - $8.42 Million	44,671 Added 0.46%	9,785,272 $1.7 Billion
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $1.63 Billion - $1.86 Billion	9,740,601	9,740,601 $1.82 Billion

Others Institutions Holding AMGN

# of Institutions

2,929

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Amgen Inc Transaction History